<SEC-DOCUMENT>0001493152-18-001284.txt : 20180131
<SEC-HEADER>0001493152-18-001284.hdr.sgml : 20180131
<ACCEPTANCE-DATETIME>20180131115003
ACCESSION NUMBER:		0001493152-18-001284
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180125
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180131
DATE AS OF CHANGE:		20180131

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Microbot Medical Inc.
		CENTRAL INDEX KEY:			0000883975
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943078125
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19871
		FILM NUMBER:		18561621

	BUSINESS ADDRESS:	
		STREET 1:		175 DERBY ST. 27/1
		STREET 2:		.
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043
		BUSINESS PHONE:		908-938-5561

	MAIL ADDRESS:	
		STREET 1:		175 DERBY ST. 27/1
		STREET 2:		.
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STEMCELLS INC
		DATE OF NAME CHANGE:	20000524

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTOTHERAPEUTICS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 13 OR 15(d) OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
of report (Date of earliest event reported): January 25, 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>MICROBOT
MEDICAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
Name of Registrant as Specified in Charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-19871</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>94-3078125</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
    or Other Jurisdiction</B><BR>
    <B>of Incorporation)</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Commission</B><BR>
    <B>File Number)</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(I.R.S.
    Employer</B><BR>
    <B>Identification No.)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25
Recreation Park Drive, Unit 108</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hingham,
MA 02043</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address
of Principal Executive Offices) (Zip Code)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registrant&rsquo;s
telephone number, including area code: (781) 875-3605</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Former
Name or Former Address, if Changed Since Last Report)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0.25in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
[&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
3.02. Unregistered Sales of Equity Securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
November 22, 2017 through January 25, 2018, the holder of the Series A Convertible Preferred Stock, par value $0.01 per share
(the &ldquo;Preferred Stock&rdquo;), of Microbot Medical Inc. (the &ldquo;Registrant&rdquo;), converted an aggregate of 2,436
shares of the Preferred Stock for an aggregate of 2,436,000 shares of the Registrant&rsquo;s common stock. Pursuant to the terms
of conversion of the Preferred Stock, each such share is convertible, upon request and for no additional consideration, into 1,000
shares of the common stock of the Registrant. The issuances of the 2,436,000 shares of common stock were exempt from registration
under Section 4(a)(2) under the Securities Act of 1933, as amended and the rules promulgated thereunder (the &ldquo;Securities
Act&rdquo;) as transactions not involving a public offering to a single existing stockholder who is an accredited investor, and/or
3(a)(9) under the Securities Act as the Preferred Stock was exchanged for common stock by an existing security holder and no commission
or other remuneration was paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 11, 2017, the Registrant issued an aggregate of 70,000 shares of the Registrant&rsquo;s common stock to a consultant
as consideration for services. The issuance of the shares was exempt from registration under Section 4(a)(2) under the Securities
Act as a transaction not involving a public offering, as the issuance thereof was made to a limited number of persons or entities
as compensation for services rendered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
7.01 Regulation FD Disclosure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 31, 2018, the Registrant issued a press release announcing that it will host regularly scheduled Townhall Meetings to
allow shareholders and interested investors to get updates and participate in a Q&amp;A session with senior executives of the
Company. The initial Townhall Meeting is scheduled for Thursday, February 1, 2018 at 4:30pm ET.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be
&ldquo;filed&rdquo; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to
the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including
Exhibit 99.1).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
9.01 Financial Statements and Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.7in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="width: 0.15in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex99-1.htm">Press Release</A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>MICROBOT MEDICAL INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Harel Gadot</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,
    President and <BR>
Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    January 31, 2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif; margin-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 94; width: 250"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.6pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.6pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">Microbot
Medical Inc. to Initiate Townhall Meetings</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.6pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.6pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; letter-spacing: 0pt"><I>Initial
Event Planned for Thursday, February 1st at 4:30pm ET</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.6pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; letter-spacing: 0pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hingham,
MA &ndash; January 31, 2018 &ndash; Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design
and development of transformational micro-robotic medical technologies, today announced that it will host regularly-scheduled
Townhall Meetings to allow shareholders and interested investors to get updates and participate in a Q&amp;A session with senior
executives of the Company. The initial Townhall Meeting is scheduled for Thursday, February 1, 2018 at 4:30pm ET. Harel Gadot,
Chief Executive Officer, President and Chairman, and Hezi Himelfarb, General Manager and Chief Operating Officer, will be available
to address participant questions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
have had a number of significant accomplishments since becoming a publicly-traded company just over a year ago &ndash; strengthening
our balance sheet, IP and we recently entered into an agreement with CardioSert to acquire a novel technology to enhance existing
technology platforms &ndash; just to name a few,&rdquo; commented Mr. Gadot. &ldquo;I believe it&rsquo;s important to maintain
an open communications policy with our shareholders. The bi-monthly Townhall Meetings is an efficient approach to ensure alignment
on our strategy, demonstrate progress and provide updates.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
both &ldquo;listen-only&rdquo; participants and those participants who wish to ask question, the dial-in number is 888-539-3686
(U.S./Canada) or 719-325-2214 (international) and the Conference ID is 8365949. An accompanying video presentation may be accessed
at the following address <B><U>https://streaming.webcasts.com/starthere.jsp?ei=1179998&amp;tp_key=d5abe459e6</U></B> or via the
&lsquo;Investors&rsquo; section, under &lsquo;Presentations and Resources&rsquo; of the Company&rsquo;s website at www.microbotmedical.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
replay of the &lsquo;Townhall Meeting will be available for seven business days beginning about two hours after the conclusion
of the live call, by dialing 888-203-1112 (U.S./Canada) or +1 719-457-0820 (international) and providing the Conference ID 8365949.
An archived webcast will also be available and may be accessed in the &lsquo;Investors&rsquo; section of the Company&rsquo;s website
at www.microbotmedical.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: justify; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Microbot Medical Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: justify; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Microbot,
which was founded in 2010 and commenced operations in 2011, became a NASDAQ listed company on November 28, 2016. The Company specializes
in transformational micro-robotic medical technologies leveraging the natural and artificial lumens within the human body. Microbot&rsquo;s
current platforms, ViRob and TipCAT, are comprised of two highly advanced micro-robotic technologies, from which the Company is
currently developing its first two product candidates: the Self Cleaning Shunt, or SCS, for the treatment of hydrocephalus and
Normal Pressure Hydrocephalus, or NPH; and a self-propelling, semi-disposable endoscope that is being developed initially for
use in colonoscopy procedures. Further information about Microbot Medical is available at http://www.microbotmedical.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ViRob technology is a revolutionary autonomous crawling micro-robot which can be controlled remotely or within the body. Its miniature
dimensions allow it to navigate and crawl in different spaces within the human body, including blood vessels, the digestive tract
and the respiratory system. Its unique structure gives it the ability to move in tight spaces and curved passages as well as the
ability to remain within the human body for prolonged time. To learn more about ViRob please visit http://www.microbotmedical.com/technology/virob/.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TipCAT
is a transformational self-propelled, flexible, and semi-disposable endoscope providing see &amp; treat capabilities within tubular
lumens in the human body such as the colon, blood vessels, and the urinary tract. Its locomotion mechanism is perfectly suitable
to navigate and crawl through natural &amp; artificial tubular lumens, applying the minimal necessary pressure to achieve the
adequate friction required for gentle, fast, and safe advancement within the human body. To learn more about TipCAT visit http://www.microbotmedical.com/technology/tipcat/.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: justify; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Safe
Harbor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: justify; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Statements
pertaining to future financial and/or operating results, future growth in research, technology, clinical development, and potential
opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs,
goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical
fact (including, but not limited to statements that contain words such as &ldquo;will,&rdquo; &ldquo;believes,&rdquo; &ldquo;plans,&rdquo;
&ldquo;anticipates,&rdquo; &ldquo;expects&rdquo; and &ldquo;estimates&rdquo;) should also be considered to be forward-looking
statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development
and/or commercialization of potential products, the outcome of its further evaluation of the CardioSert technology, uncertainty
in the results of clinical trials or regulatory approvals, need and ability to obtain future capital, and maintenance of intellectual
property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as
such should be evaluated together with the many uncertainties that affect the businesses of Microbot Medical Inc. particularly
those mentioned in the cautionary statements found in Microbot Medical Inc.&rsquo;s filings with the Securities and Exchange Commission.
Microbot Medical disclaims any intent or obligation to update these forward-looking statements.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contacts:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Analysts
and Institutional Investors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
Polyviou</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVC
Group</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mpolyviou@evcgroup.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">646-445-4800</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Individual
Investors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeremy
Roe</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integra
Consulting Group llc</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">jeremy@integracg.net</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(925)
262-8305</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">###</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $& K@# 2(  A$! Q$!_\0
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M^JR?]_?\]/\ ''M\]^./BC]@D.B>&[:34-4D_<1"U/VC_/IS]3[=A\,_V/\
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M]^M2T %%1JXV_AQ[CM]*DH **** "BBB@ HHHH **** "BBD.[MC\?Z?_7H
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MS;V%O#)YO&2!W(Z]?PZ^]>]QH^/GX_S[\^GK_2O]M,OKK%8#"U^Z5_R_S/\
M&#'TJF&Q^*HO=2?XNZ_"2_IDRJ%'%.HHKT#F"BBB@ HHHH **** (^_E]OU]
M?Y^U(7YVLIZ=>Q[<?_K]:EHH \M\6_"?X?>-[:>T\0>%M-OEG'S2O;?-]1G
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS_4_=K][H^MU_7WHEHJ/_EG_ )_O4,_I^?\ ]:MADE%%% !1110!\]?M.?\
M)(_$O_7I/_2OXU/B(]XGQ USR;EX_P#2KD_YZ^O;-?V6?M,_\DC\1_\ 7N__
M *3M7\:_Q%_Y'WQ!_P!?%S_.NS#=/Z[@>;[]223?]LDZ_P"><]<?K7!_$A[Q
MM,_?7,DG/0>GTYKT"O/_ (D_\@D?C_6M#G/W _X(Y[_+C_'K]?\ ]7X_C7]-
MR?='X_S-?S)?\$<_]2GT/\EK^FU/NC\?YFO/J_:^7Z'0.HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3YMO;=C_/X_IGVI:** "BB
MB@ HJ/?\W^S]/U_SV[9J2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH Y+Q?HBZ]X<U32N@NK69$SW)#-S^)[?3!Z5_(3^U!IOB?
MX(?&SQ ^MPW%OH^H7]UY4OE?Y_'O_(_V.LW/RG@# [?Y^O7\A7QI^U%^Q[X
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M*\WZX[_YZ<YK\_[CXK^)'O)/WS\?GT_'ZUT>P\_Q_P" 9^T\OQ_X!_2)>?\
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M]>>N:RM7U[2M$M9+G4KRWMHXQG][(.?3@\Y_SFOE_P <?M6^$= 6>UL\R3@
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MQ_\ ?T?_ !5/&Q_N,/P_'L?\C'2OYU-2_;;\>)]S6_\ R://T_/(]#BLN/\
M;V^)=@V_^V.!T_>^_7G//M_]:M?J];S^Y?Y ?TB45^"G@_\ X*<:EILD?_"3
MS?:(Q]?ZX[?EZ5]Y?"?]O[X2_$A[>SEO8-.O)!TEE&#TYQC^7M2]E/\ E_%
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M_6BK]KY?H!_<-X(A>'PKHL;_ //C;@?ESV^GXUU.UL8[>F?\CWZ_K7Y :?\
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M]/E^IT'ZFU^"_P#P58U^_P!'DT^:S?\ U><XY]Q_/O\ XU^]%?@/_P %8?\
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M]_X*D>(;_P />.(IK6:3O^ZZ]N>_?'\\9K\<+KXS:DRG_0_RS_\ 7'\\<8[
M?KO_ ,%7/G\9=>!+P?K_ $X-?B'*B<_)U_3'3/Z<?7FNVG_!_KR,_:>7X_\
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MQ;GSHO*EQC_/^1BN/TO5;+6+?="\<=Q_SR]OP_K6JGWS]?\ V44@/TR_8_\
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M<?E[8K^X#]E>9X?@WI=P?^6=A:G';BT'<>A_#/Z<]?I\OU-*?7Y?J?&_[?\
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M^E>%F_"W#?%F58G+.(\K^OX+'*WW?TO,]C(^(,^X7Q_]I<-YI]0QFW_!.?\
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M/_X)M_\ )(]'^3_EUMO3]>/Y\=_2OX[_ !C_ ,CAI?\ U_6O]:_L3_X)M_\
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M5<U#4M*N9KCR[^W_ -;_ ,]?\_GZ'WJG9W^F^88?MEO^,O\ (?\ UJ[?XO\
M5[W^[L<YY'XQ_P"1PTO_ *_K7^M?V)_\$V_^21Z/_P!>EM_2OXY/&5Y9IXPT
M;9<V\G^GVW_+7_./\,=C7]B__!-J0-\(M((Z_9+?O[$Y]<\?KFN.OT^7ZFD/
MWN_3Y6[^NQ^G->&_M$?\DH\4_P#8/N?Y5[E7AW[0[I'\*/%+/T%A<?RKG-#^
M-#XC?\CAKW_7]=5YG_RT_P _W:]$^(FI:5_PF'B1&O+>.3^U+G]V)>O?W_\
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M9?\ /./08_G7]S_P<1T\":,'ZFUMR/R_S_6LZE/V7H=!^%/_  5<_P"1M/\
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MGX?Y^F<]!SGU;\!_VA_B%\'+ZW32M8N+FSCE_P"/7S>O^?\ 'C.*_73X?_\
M!2/Q5?Z?;PWEM^\XZX^N/Y=?QK^?.WN;FS!>VFZ^_P#+C..I]*W+/QUXGL/^
M/:;/T[=1QZ?C^5'LO[OX_P#! _H@UC]L#4O$EO(+^^_L^W_YZ^:/\_K7PO\
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MF_LI/+N+>VS'[>OY=/\ ]7'\KGQB_; \?V'C;7-'AO[B/RY;F&(>;^.#_/\
MF3WTIT_:^@']:EGXM\-W\?G6VK6\D?/_ "U&/R_KU[5Q^J?&CP!I%Q]FO];M
MX).W[T?X?X\=.:_E3\'_ /!07QMX2T>XT>::\U74+CB***7ISZ_XC_ZW@_C#
M]J+XR:WJDE_J5GK&GV5Y_JO-^U_U^OY?2M/8>?X_\ #^TOP[XY\*^+0?[!U6
MVU#O^ZE.?7C'\A6QJ>L:5I$8DU&\B@"<_O93D^Y[^_3^=?QZ?L]_MC?%'P!X
MPM[VYUN?^QA_K/-NO7_/Y]:^E?VA/^"E/B#Q59QZ3X,BO-0U"2+][]@_/O\
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M<&7_ .OR?\XK^F[PIXGO/'/['?\ ;&J/YEW<:"WG2?6T&#^1/Y^PK.I3]EZ
M?R4?&Y]_B3Q)LX_XFESCU_'GG'8_UK]8/^",>/\ A)-0W]?-./\ Z_;KCIST
MQS7Y/?&U$3Q5XDV'_F*7/^/X<]N_Y5^L/_!&=,>)M0=^GF_YZ?\ UORK6I_!
M_KS,_P#EY_78_IDD[?C_ $J2HY.WX_TIR?='X_S-<QH.HHHH **** "BBB@
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M:IQ_GK[_ (FOZ=/^"1?[OX;[.XM<\^WX]./Y<UIB>O\ 78SI?9^?ZGS_ /\
M!3K]G+P-X2LHM>\,:7;Z6(XO]5:Q8./?\?PK\ ]+N9/^$X\+OUDCO_\ 6_\
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MQO\ P4>\3Z/XD\0:A<VSV\K_ .D_ZK].>.OZ?D:QI7=57W_X8*G3Y_H?%_[
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M9C_D*7/X_P"3CGC^M?K#_P $9_\ D9M0W?\ /7VSGMCW_P FG4_@_P!>8?\
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1[>WK110!)1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
